Please assess the completion status of the following clinical trial:

Trial Title: Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 55-85y;~* Diagnosis of COVID-19;~* Hospitalized patients.~Exclusion Criteria:~* Active heart disease or active cancer at time of recruitment;~* Patients in Intensive Care Unit at the time of recruitment;~* Patents with alanine transaminase and aspartate transaminase greater than 5 times the upper limit of normal at any time;~* Patients requiring \>4L per minute of oxygen support at the time of recruitment.

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Active arm (Type: EXPERIMENTAL): The active supplements are glycine and N-acetylcysteine
- Placebo arm (Type: PLACEBO_COMPARATOR): The placebo arm is alanine

Based on this trial design, predict the completion outcome and termination type (if applicable).